Genomic Health Inc. (GHDX) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Join SI Premium – FREE
Genomic Health Inc. (NASDAQ: GHDX) reported Q1 EPS of ($0.01), $0.03 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $49.8 million versus the consensus estimate of $48.69 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Stantec (STN) Tops Q2 EPS by 47c
- Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
